IN2013MU03430A - - Google Patents

Info

Publication number
IN2013MU03430A
IN2013MU03430A IN3430MU2013A IN2013MU03430A IN 2013MU03430 A IN2013MU03430 A IN 2013MU03430A IN 3430MU2013 A IN3430MU2013 A IN 3430MU2013A IN 2013MU03430 A IN2013MU03430 A IN 2013MU03430A
Authority
IN
India
Prior art keywords
acebrophylline
roflumilast
salts
pharmaceutical compositions
relates
Prior art date
Application number
Other languages
English (en)
Inventor
Yatendra Kumar
Kapileswar Swain
Vijay Suggala
Dadapeer Shaik
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN3430MU2013 priority Critical patent/IN2013MU03430A/en
Priority to PCT/IB2014/065637 priority patent/WO2015063669A1/en
Publication of IN2013MU03430A publication Critical patent/IN2013MU03430A/en

Links

IN3430MU2013 2013-10-30 2014-10-27 IN2013MU03430A (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN3430MU2013 IN2013MU03430A (es) 2013-10-30 2014-10-27
PCT/IB2014/065637 WO2015063669A1 (en) 2013-10-30 2014-10-27 Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3430MU2013 IN2013MU03430A (es) 2013-10-30 2014-10-27

Publications (1)

Publication Number Publication Date
IN2013MU03430A true IN2013MU03430A (es) 2015-07-31

Family

ID=54397487

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3430MU2013 IN2013MU03430A (es) 2013-10-30 2014-10-27

Country Status (1)

Country Link
IN (1) IN2013MU03430A (es)

Similar Documents

Publication Publication Date Title
MX2018002990A (es) Uso de la akkermansia pasteurizada para tratar trastornos metabolicos.
PH12018501206A1 (en) Antibody molecules to pd-1 and uses thereof
MX2015006234A (es) Uso de akkermansia para tratar trastornos metabolicos.
MX2021008113A (es) Composiciones farmaceuticas que comprenden un antagonista de il-4r para usarse en el tratamiento del asma.
MX2022001043A (es) Moleculas de anticuerpo que se unen a lag-3 y usos de las mismas.
MX2023000079A (es) Composiciones farmaceuticas que comprenden un antagonista de il-4r para usarse en el tratamiento de sinusitis cronica con polipos nasales.
MY197345A (en) Antibody molecules to april and uses thereof
MX2021002406A (es) Composiciones farmaceuticas que comprenden un inhibidor de il-4r para usarse en el tratamiento de la esofagitis eosinofilica.
EP2875359A4 (en) COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING METABOLISM SYNDROME DISEASES
TR201811764T4 (tr) Kinaz inhibitörleri olarak aminoheteroaril benzamidleri.
IL283432A (en) Preparations, methods and systems for the treatment of skin disorders
EA202090632A1 (ru) Способы и композиции для лечения расстройств с использованием фоллистатиновых полипептидов
MX2016005446A (es) Intervenciones a base de angiopoyetina para tratar la malaria cerebral.
MX2020001756A (es) Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos.
EP2989123A4 (en) METHODS AND COMPOSITIONS FOR TREATING COAGULATION DISORDERS
PH12017500348A1 (en) Tetrahydroquinoline derivatives as bromodomain inhibitors
WO2014159669A3 (en) Aptamers that bind to il-6 and their use in treating or diagnosing il-6 mediated conditions
WO2014182928A3 (en) Stat6 inhibitors
MX2016000037A (es) Inhibidores de replicacion viral, su proceso de preparacion y sus usos terapeuticos.
PH12016501658A1 (en) Sialylated glycoprotein compositions and uses thereof
EA201791689A1 (ru) Новые композиции и способы лечения и/или предупреждения хронического обструктивного заболевания легких
PT3209294T (pt) Composição farmacêutica para uso no aumento do trofismo da mucosa nasal
MX2016001691A (es) Moleculas de union al receptor bag3 para uso como un medicamento.
IN2013MU03430A (es)
TR201716209A2 (tr) Arformoterol ve umeklidinyum içeren yeni farmasötik bileşimler.